FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969866098> ?p ?o ?g. }

• W1969866098 endingPage "454" @default.
• W1969866098 startingPage "445" @default.
• W1969866098 abstract "Background Fetal alcohol spectrum disorders (FASD) result from fetal exposure to alcohol and are the leading cause of mental retardation in the United States. There is currently no effective treatment that targets the causes of these disorders. Thus, novel therapies are critically needed to limit the neurodevelopmental and neurodegenerative pathologies associated with FASD. Methods A neonatal mouse FASD model was used to examine the role of the neuroimmune system in ethanol (EtOH)-induced neuropathology. Neonatal C57BL/6 mice were treated with EtOH, with or without pioglitazone, on postnatal days 4 through 9, and tissue was harvested 1 day post treatment. Pioglitazone is a peroxisome proliferator-activated receptor (PPAR)-γ agonist that exhibits anti-inflammatory activity and is neuroprotective. We compared the effects of EtOH with or without pioglitazone on cytokine and chemokine expression and microglial morphology in the hippocampus, cerebellum, and cerebral cortex. Results In EtOH-treated animals compared with controls, cytokines interleukin-1β and tumor necrosis factor-α mRNA levels were increased significantly in the hippocampus, cerebellum, and cerebral cortex. Chemokine CCL2 mRNA was increased significantly in the hippocampus and cerebellum. Pioglitazone effectively blocked the EtOH-induced increase in the cytokines and chemokine in all tissues to the level expressed in handled-only and vehicle-treated control animals. EtOH also produced a change in microglial morphology in all brain regions that was indicative of microglial activation, and pioglitazone blocked this EtOH-induced morphological change. Conclusions These studies indicate that EtOH activates microglia to a pro-inflammatory stage and also increases the expression of neuroinflammatory cytokines and chemokines in diverse regions of the developing brain. Further, the anti-inflammatory and neuroprotective PPAR-γ agonist pioglitazone blocked these effects. It is proposed that microglial activation and inflammatory molecules expressed as a result of EtOH treatment during brain development contribute to the sequelae associated with FASD. Thus, pioglitazone and anti-inflammatory pharmaceuticals more broadly have potential as novel therapeutics for FASD." @default.
• W1969866098 created "2016-06-24" @default.
• W1969866098 creator A5019862535 @default.
• W1969866098 creator A5046288654 @default.
• W1969866098 creator A5055938141 @default.
• W1969866098 creator A5079591855 @default.
• W1969866098 creator A5083901960 @default.
• W1969866098 date "2015-02-19" @default.
• W1969866098 modified "2023-10-14" @default.
• W1969866098 title "Pioglitazone Blocks Ethanol Induction of Microglial Activation and Immune Responses in the Hippocampus, Cerebellum, and Cerebral Cortex in a Mouse Model of Fetal Alcohol Spectrum Disorders" @default.
• W1969866098 cites W1534334215 @default.
• W1969866098 cites W1539507436 @default.
• W1969866098 cites W1648996057 @default.
• W1969866098 cites W1656162023 @default.
• W1969866098 cites W1762454906 @default.
• W1969866098 cites W1874178505 @default.
• W1969866098 cites W1963524612 @default.
• W1969866098 cites W1971668430 @default.
• W1969866098 cites W1972296893 @default.
• W1969866098 cites W1975028061 @default.
• W1969866098 cites W1975931952 @default.
• W1969866098 cites W1982657399 @default.
• W1969866098 cites W1985941384 @default.
• W1969866098 cites W1994844104 @default.
• W1969866098 cites W2007023810 @default.
• W1969866098 cites W2009617157 @default.
• W1969866098 cites W2009962309 @default.
• W1969866098 cites W2010843703 @default.
• W1969866098 cites W2018062658 @default.
• W1969866098 cites W2020206702 @default.
• W1969866098 cites W2020337399 @default.
• W1969866098 cites W2020634566 @default.
• W1969866098 cites W2029317114 @default.
• W1969866098 cites W2032329560 @default.
• W1969866098 cites W2059154371 @default.
• W1969866098 cites W2064735480 @default.
• W1969866098 cites W2064891273 @default.
• W1969866098 cites W2065412979 @default.
• W1969866098 cites W2078160072 @default.
• W1969866098 cites W2080067668 @default.
• W1969866098 cites W2081609922 @default.
• W1969866098 cites W2082429191 @default.
• W1969866098 cites W2083817323 @default.
• W1969866098 cites W2091589506 @default.
• W1969866098 cites W2092281141 @default.
• W1969866098 cites W2094432783 @default.
• W1969866098 cites W2094683737 @default.
• W1969866098 cites W2098038342 @default.
• W1969866098 cites W2112880160 @default.
• W1969866098 cites W2120911948 @default.
• W1969866098 cites W2123447182 @default.
• W1969866098 cites W2130189043 @default.
• W1969866098 cites W2131282394 @default.
• W1969866098 cites W2134219041 @default.
• W1969866098 cites W2137554480 @default.
• W1969866098 cites W2140348169 @default.
• W1969866098 cites W2143295652 @default.
• W1969866098 cites W2145136979 @default.
• W1969866098 cites W2145938600 @default.
• W1969866098 cites W2149321600 @default.
• W1969866098 cites W2152948116 @default.
• W1969866098 cites W2154619412 @default.
• W1969866098 cites W2155471406 @default.
• W1969866098 cites W2156670938 @default.
• W1969866098 cites W2163242854 @default.
• W1969866098 cites W2166767261 @default.
• W1969866098 cites W2168922242 @default.
• W1969866098 doi "https://doi.org/10.1111/acer.12639" @default.
• W1969866098 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4348240" @default.
• W1969866098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25703036" @default.
• W1969866098 hasPublicationYear "2015" @default.
• W1969866098 type Work @default.
• W1969866098 sameAs 1969866098 @default.
• W1969866098 citedByCount "122" @default.
• W1969866098 countsByYear W19698660982015 @default.
• W1969866098 countsByYear W19698660982016 @default.
• W1969866098 countsByYear W19698660982017 @default.
• W1969866098 countsByYear W19698660982018 @default.
• W1969866098 countsByYear W19698660982019 @default.
• W1969866098 countsByYear W19698660982020 @default.
• W1969866098 countsByYear W19698660982021 @default.
• W1969866098 countsByYear W19698660982022 @default.
• W1969866098 countsByYear W19698660982023 @default.
• W1969866098 crossrefType "journal-article" @default.
• W1969866098 hasAuthorship W1969866098A5019862535 @default.
• W1969866098 hasAuthorship W1969866098A5046288654 @default.
• W1969866098 hasAuthorship W1969866098A5055938141 @default.
• W1969866098 hasAuthorship W1969866098A5079591855 @default.
• W1969866098 hasAuthorship W1969866098A5083901960 @default.
• W1969866098 hasBestOaLocation W19698660982 @default.
• W1969866098 hasConcept C126322002 @default.
• W1969866098 hasConcept C13373296 @default.
• W1969866098 hasConcept C134018914 @default.
• W1969866098 hasConcept C170493617 @default.
• W1969866098 hasConcept C185592680 @default.
• W1969866098 hasConcept C25498285 @default.
• W1969866098 hasConcept C2776914184 @default.
• W1969866098 hasConcept C2777180221 @default.

• next